Showing 1 - 20 of 248 results
Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.
ANSTO has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99 (Mo-99), with less enrichment of uranium-235 (U-235) and produce less waste.
Blake Orr from ARPANSA review the Netflix series Radioactive Emergency.
Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.
Explore ANSTO's range of publications and reports available for the public.
Australia has one multi-purpose nuclear reactor, the Open Pool Light Water Reactor (OPAL) and it is not used to generate ‘nuclear power’.
ARPANSA has given ANSTO approval to begin testing the neutron reflectometer, Spatz
Datasets from the Aerosol Sampling Program.
A neutron reflectometer for vertical samples.
See details of previously published customer updates from our Health products team.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.